Masimo expected to grow through 2025 as it branches out, analyst says

Masimo (Nasdaq: MASI) should enjoy growth through the middle of the next decade, thanks to its exploration of opportunities outside its core market that are more driven by hospital automation, according to a new equity research report out of Barclays. Masimo is on track to having 8–10% top-line growth and 12–15% earnings per share growth through

K2M leads the pack with 3D printing for spine, analysts say

K2M (Nasdaq: KTWO) continues to lead the 3D printed spine device market with its new 3D printed Mojave expandable cage and its Cascadia family of 3D printed implants, according to a new equity research report out of Barclays. Leesburg, Va.–based K2M presently has a 3D printed portfolio with 10 approved products making up about 12%